BSEVeerhealth Care Ltd· Pharmaceuticals & BiotechnologyHighPositive
Announced Thu, 27 Nov, 2025 · 17:39 IST

We are pleased to inform that after completion of initial supply order to one of India''s leading Company in FMCG products, Company has received fresh order for manufacturing and supply ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.9%Reaction day
₹18.26
prior close
₹18.75
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+4.0% vs market
Pharmaceuticals peers, median of 156sector-0.0%+4.0% vs sector

On the reaction day the stock moved 4.0 pts more than Nifty Microcap 250 and 4.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.3
10m
+1.8
15m
+1.3
30m
+2.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+3.9-0.1+4.0-0.0+4.0
Next day
+3.1-0.3+3.3-0.2+3.3
2d
+2.9-0.9+3.8-0.4+3.3
3d
+2.7-1.3+4.1-1.0+3.8
4d
+6.0-1.9+7.8-1.1+7.1
5d
+5.5-3.0+8.4-1.4+6.9
1w
+5.0-3.4+8.4-2.1+7.2
15d
-2.4-3.4+1.0-2.1-0.3
1m
+2.0-3.9+5.8-2.5+4.5
2m
-3.9-9.4+5.5-7.8+3.9
3m
+6.8-10.0+16.8-11.0+17.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Veerhealth Care Ltd has received a new order worth Rs. 1.72 crore from one of India's leading FMCG companies for manufacturing and supplying personal care products under the private label category. This is a follow-up order after the successful completion of an initial supply order from the same client. The order is domestic in nature and needs to be executed within 30 days. The company stated that the new order represents a significant opportunity and anticipates additional growth in turnover. The client's name has not been disclosed citing confidentiality, and there are no related party interests involved.

Likely market impact

The fresh order reinforces the company's relationship with a major FMCG client and could contribute to near-term revenue growth. However, the order size of Rs. 1.72 crore is relatively modest, so the impact on the stock price may be limited unless it signals a larger pipeline of private-label contracts.